Eisai U.S. Neurology

We’re pleased to share an update on the supplemental biologics license application for the intravenous maintenance dosing regimen of our treatment for early #Alzheimersdiease. Read more: https://ow.ly/C7Rl50UNpJ6

When Pako started noticing what he thought were Alzheimer’s disease (AD) symptoms, he spoke with his health care provider (HCP). His HCP asked about Pako’s family history of AD, which helped confirm his diagnosis. In the next episode of our Care Pair series, Pako and Zahydie share this part of their story and how their background and culture have influenced their AD journey: https://lnkd.in/gTKBYVJt #AlzheimersDisease #EndAlz

“I was the first who realized something was going on. I felt like I was forgetting a lot of things.” Our Care Pair series shares the inspiring journey of Pako, who is living with Alzheimer’s disease (AD), and his wife and care partner, Zahydie. They bravely share their story, from the first time they noticed Pako’s AD symptoms to their journey through testing, diagnosis and beyond. Subscribe and stay updated on Pako and Zahydie’s journey: https://lnkd.in/ejPUxbMg #AlzheimersDisease #EndAlz

The role of a care partner is invaluable. Today, on National Caregivers Day, we celebrate the profound impact care partners have on the lives of those living with AD. Join us next week for the launch of our Care Pair series, where we spotlight their unique journeys with a deep dive into their stories. Subscribe to our YouTube channel to stay up to date with content: https://ow.ly/PVwx50URAO7 #AlzheimersDisease #neurology #NationalCaregiversDay

In Alzheimer’s disease (AD), use of anti-amyloid treatments has been associated with amyloid-related imaging abnormalities (ARIA). In this video, expert neuroradiologist Jerome Barakos, MD, discusses how ARIA are detected and diagnosed, including guidance on imaging sequences and differential diagnoses: https://ow.ly/I3eg50UXvFz #EndAlz #neurology

Our library of Alzheimer’s disease (AD) resources for health care providers is always expanding. Visit our YouTube channel and subscribe to view the Unlocking Alzheimer’s Disease series featuring Dung Trinh, MD and to stay updated on new content releases: https://ow.ly/Wfot50URAQ9 #AlzheimersDisease #neurology #EndAlz

Experts believe that the timely identification of changes to Alzheimer’s disease (AD) biomarkers – when combined with other testing methods – may be one of the most promising paths to earlier AD diagnosis. Suzanne Schindler, MD, PhD, provides information on key AD biomarkers in this foundational video: https://ow.ly/hTVp50UXrZQ #AlzheimersDisease #EndAlz #neurology

Don’t miss your chance to register for this insightful Medscape webinar happening on Feb. 12!

As we honor Black History Month, it’s crucial to address the urgent need for greater diversity in AD clinical trials. Ensuring participants better represent the diverse U.S. population is essential for advancing research and development. Learn more: https://ow.ly/5Sxl50URAJf #AlzheimersDisease #neurology #EndAlz

You’re invited to join us on Wednesday, February 12, from 1-2 PM ET for a Medscape webinar on the future of Alzheimer’s disease (AD) diagnosis. Discover how blood-based biomarkers (BBMs) are revolutionizing the field and can be used to expedite AD diagnosis. We are honored to have esteemed experts Professor Atsushi Iwata, Professor Sam Gandy, and Professor Charlotte Teunissen share insights on the latest advancements in BBMs in AD clinical practice. U.S. Healthcare Professionals: Don’t miss this opportunity to stay at the forefront of AD diagnosis. Medscape members can register now: https://bit.ly/4gOn9kj Not a Medscape member? Sign up for a free account to register for the webinar: https://wb.md/3DTE6eE #AlzheimersDisease #neurology